# Jiangsu NHWA Pharmaceutical

> Jiangsu NHWA Pharmaceutical is a VC fund in Xuzhou backing Medical and Therapeutics. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Xuzhou, China
- Total investments: 1
- Last investment: Mar 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/jiangsu-nhwa-pharmaceutical-co-ltd/
- Website: http://www.nhwa-group.com/about/en-hua-gai-kuang.htm

Jiangsu NHWA Pharmaceutical is a VC fund in Xuzhou focused on Medical and Therapeutics. Jiangsu Enhua Pharmaceutical Co., Ltd. is strategically positioned in the central nervous drug market, mainly engaged in the development, production and sales of central nervous system drugs. It is a company specializing in the market segment of central nervous drugs. The main categories include anesthesia and spirit. Class and Neurology, throughyears of unremitting efforts in product development, production and service, the company has established a complete series of central nervous system drug products and marketing network, and strive to build an important domestic producer and sales of central nervous system drugs. Business.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Therapeutics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Neuro3 Therapeutics | Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases. | $3.5M | Seed | Mar 06, 2025 |  |

1 of 1 investments shown.

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alibaba Entrepreneurs Fund](https://shizune.co/investors/profile/alibaba-entrepreneurs-fund) — VC Fund
- [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund
- [Gobi Partners](https://shizune.co/investors/profile/gobi-partners) — VC Fund

## Featured in investor lists
- [Medical VC Funds in Hong Kong](https://shizune.co/investors/medical-vc-funds-hong-kong)
- [Medical Investors in Hong Kong](https://shizune.co/investors/medical-investors-hong-kong)

## FAQ

### What does Jiangsu NHWA Pharmaceutical invest in?

Jiangsu NHWA Pharmaceutical invests primarily in Medical and Therapeutics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Hong Kong. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jiangsu NHWA Pharmaceutical last invest?

The most recent investment recorded for Jiangsu NHWA Pharmaceutical closed in Mar 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co